Skip to main content

Table 1 Clinical data of the study population

From: Differential expression of long non-coding RNA Regulator of reprogramming and its molecular mechanisms in polycystic ovary syndrome

Variables

All subjects (N = 135)

P value

Control (n = 67)

PCOS patients

(n = 68)

Age (years)

29.96 ± 4.49

30.35 ± 4.58

0.611

BMI (kg/m2)

21.93 ± 2.87

23.01 ± 3.11

0.037

FSH (mIU/ml)

6.74 ± 1.89

6.65 ± 2.06

0.797

LH (mIU/ml)

4.55 ± 2.09

9.91 ± 5.99

 < 0.001

E2 (pg/ml)

46.71 ± 18.25

48.96 ± 16.38

0.452

PRL (ng/ml)

13.91 ± 4.91

13.71 ± 5.91

0.830

TES (ng/l)

0.422 ± 0.17

1.45 ± 0.38

 < 0.001

AMH (ng/ml)

3.037 ± 1.05

10.89 ± 3.54

 < 0.001

  1. Note: PCOS polycystic ovary syndrome, BMI body mass index, FSH follicle-stimulating hormone, LH luteinizing hormone, E2 estradiol, TES testosterone, PRL prolactin, AMH anti-Mullerian hormone. Data are expressed as n or mean ± standard deviation
Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us